IOVA - Iovance Biotherapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.
IPO Date: October 23, 2013
Sector: Healthcare
Industry: Biotech
Market Cap: $6.73B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.50 | 3.74%
Avg Daily Range (30 D): $0.50 | 4.33%
Avg Daily Range (90 D): $0.33 | 4.43%
Institutional Daily Volume
Avg Daily Volume: 4.76M
Avg Daily Volume (30 D): 14.85M
Avg Daily Volume (90 D): 15.03M
Trade Size
Avg Trade Size (Sh.): 199
Avg Trade Size (Sh.) (30 D): 211
Avg Trade Size (Sh.) (90 D): 264
Institutional Trades
Total Institutional Trades: 6,046
Avg Institutional Trade: $2.59M
Avg Institutional Trade (30 D): $3.55M
Avg Institutional Trade (90 D): $3.17M
Avg Institutional Trade Volume: .26M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.13M
Avg Closing Trade (30 D): $16.87M
Avg Closing Trade (90 D): $9.79M
Avg Closing Volume: 443.44K
 
News
Oct 20, 2026 @ 11:55 AM
These 2 Medical Stocks Could Beat Earnings: Why Th...
Source: Zacks.Com
Oct 9, 2026 @ 11:55 AM
How to Boost Your Portfolio with Top Medical Stock...
Source: Zacks.Com
Oct 2, 2026 @ 11:55 AM
These 2 Medical Stocks Could Beat Earnings: Why Th...
Source: Zacks.Com
Oct 1, 2026 @ 11:00 AM
Iovance Biotherapeutics Appoints Noah Berkowitz, M...
Source: Na
Sep 30, 2026 @ 1:22 PM
IOVA Stock Hits 52-Week High on Raised Revenue Out...
Source: Na
Splits
Sep 26, 2013 1:100
Apr 06, 2010 24:1